<DOC>
	<DOCNO>NCT02600169</DOCNO>
	<brief_summary>This study retrospective cohort study . A database create data available patient participate name patient program pembrolizumab Netherlands . This database use analysis response marker evaluation adverse event .</brief_summary>
	<brief_title>Retrospective Analysis Response Markers Adverse Events Melanoma Patients Treated With Pembrolizumab</brief_title>
	<detailed_description>This study retrospective cohort study . A database create data available patient participate name patient program pembrolizumab Netherlands . This database use analysis response marker evaluation adverse event .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Pembrolizumab</mesh_term>
	<criteria>All patient eligible treatment pembrolizumab Named Patient Program Netherlands .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>